World-class transactional team that has guided leading private equity sponsors in some of the market’s largest and most complex transactions
Function of Beauty Secures $150 Million Investment from L Catterton
Learn More
Pharmapacks Brings in $250 Million Investment From the Carlyle Group
Learn More
CSL Secures Investment From ECI Partners
Learn More
Why Cooley
- 65+ private and growth equity sponsor clients
- Represent private equity funds, management groups, consortiums, family offices, lenders and portfolio companies in the full spectrum of private equity transactions – buyouts, minority investments, growth equity investments, take-privates, spin-offs and roll-ups, leveraged recapitalizations, secondary equity transactions, royalty purchases and other similar transactions
- Unparalleled knowledge of target and portfolio company business because we represent 6,000+ private company clients and 1,500+ public company clients in technology, healthcare and other high-growth sectors
- Deal diligence, structuring and execution driven by industry-specific operational and regulatory experience
- Cradle-to-exit partnership with private equity sponsors and portfolio companies – with extensive portfolio company liquidity experience through M&A/PE and capital markets teams
- Dedicated debt finance team advises private equity sponsors and portfolio companies in a diverse range of debt finance options
-
1,000+ M&A transactions since 2017, with an aggregate value of more than $350 billion
- 185 completed IPOs in 2017 – 2020
- Primary fund counsel to 700+ investment fund clients worldwide since 2017
- Deal sourcing capabilities
ViewHide related contacts
+-
Listing Returned 0 Results.
-
{{ item.name }}
{{ item.title }}
{{ item.location }}{{ item.secondaryoffices}}
-
{{ item.name }}
{{ item.title }}
{{ item.location }}{{ item.secondaryoffices}}
ViewHide related news
+-
Listing Returned 0 Results.
ViewHide related events
+-
Listing Returned 0 Results.